CLINICAL_TRIALS
trial_result
· 2014-04-01
Clinical Trial Update: Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression [Phase 3]
Summary
A 24-week extension study of lurasidone in adults with Bipolar I Depression reports long-term safety and efficacy data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Bipolar Depression | Phase 3 | Status: COMPLETED | Results posted: 2014-04-01